Literature DB >> 2457202

What is the status of intravenous gamma-globulin for Kawasaki syndrome in the United States and Canada?

A H Rowley1, S T Shulman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457202     DOI: 10.1097/00006454-198807000-00001

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  5 in total

Review 1.  The clinical efficacy of IVGG in Kawasaki disease.

Authors:  A H Rowley; S T Shulman
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

Review 2.  Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders.

Authors:  S A Schwartz
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

3.  Kawasaki disease in Australia, 1993-95.

Authors:  J A Royle; K Williams; E Elliott; G Sholler; T Nolan; R Allen; D Isaacs
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

Review 4.  IVIG in the treatment of children with acute and chronic idiopathic thrombocytopenic purpura and the autoimmune cytopenias.

Authors:  D J Nugent
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

5.  Carbamazepine hypersensitivity and rickettsiosis mimicking Kawasaki disease.

Authors:  S Parha; A Garoufi; P Yiallouros; C Theodoridis; T Karpathios
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.